ArticleDermatology and therapy2026

Machine-Learning-Based Prediction of Long-Term Efficacy of Nemolizumab: Post Hoc Analysis of Pooled Data from Two Phase III Clinical Trials.

Makoto Kawashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.